Total planned funding: $206,228,289
Allocations
Countries/Regions
Ukraine | $206,228,289 |
Organizational Types
NGO | $49,085,879 |
Unknown | $48,770,995 |
Private Contractor | $40,067,394 |
Own Agency | $25,756,990 |
Multi-lateral Agency | $18,601,607 |
University | $11,727,000 |
Other USG Agency | $6,468,424 |
Implementing Agency | $5,500,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $86,390,786 |
Treatment | $37,373,975 |
Prevention | $23,737,120 |
Testing | $23,615,270 |
Care | $17,390,593 |
Management and Operations | $17,307,845 |
Budget Codes
OHSS: Health Systems Strengthening | $48,294,238 |
HTXS: Treatment: Adult Treatment | $24,809,980 |
HVCT: Testing: HIV Testing and Counseling | $23,615,270 |
HVSI: Strategic Information | $22,849,559 |
HVMS: Management and Operations | $17,307,845 |
HLAB: Laboratory Infrastructure | $15,246,989 |
HTXD: Treatment: ARV Drugs | $12,563,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $11,007,846 |
HVTB: Care: TB/HIV | $9,731,857 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,645,234 |
HBHC: Care: Adult Care and Support | $4,776,498 |
HMBL: Biomedical Prevention: Blood Safety | $3,323,493 |
HKID: Care: Orphans and Vulnerable Children | $2,882,238 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $217,190 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$45,705,711
Countries/Regions
Chemonics International:
$21,792,383
Countries/Regions
USG Aggregated Agencies:
$18,453,667
Countries/Regions
Pact, Inc.:
$14,545,315
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions